Your Article Summary
Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder
CNS Drugs, 06/29/09
Zarate CA et al. - Importantly, the current mainstays in the treatment of mania, lithium (a monovalent cation) and valproate (a small fatty acid) indirectly inhibit PKC. In addition, recent clinical studies with the relatively selective PKC inhibitor tamoxifen add support to the relevance of the PKC target in bipolar disorder.
Related Articles
Stability of symptoms across major depressive episodes in bipolar disorder
Bipolar Disorders, 11/20/09
Relevance Score: 70%
The role of dopamine in bipolar disorder
Bipolar Disorders, 11/19/09
Relevance Score: 70%
Epidemiology and Management of Anxiety in Patients with Bipolar Disorder
CNS Drugs, 10/30/09
Relevance Score: 70%
Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09
Relevance Score: 70%
Treatment of Bipolar Disorders and Metabolic Syndrome: Implications for Primary Care
Postgraduate Medicine, 10/15/09
Relevance Score: 70%
Today in Neuropsych Sciences...keeping you current
Receive free subspecialty "5-minute updates" via email
Subtle Neurological Signs Predict the Severity of Subacute Cognitive and Functional Impairments After Traumatic Brain Injury
Journal of Neuropsychiatry and Clinical Neurosciences, 12/17/09
Magnetoencephalographic Characteristics of Psychosis in Temporal Lobe Epilepsy
Journal of Neuropsychiatry and Clinical Neurosciences, 12/17/09
A Comparative Analysis of Completed Suicide Using High Resolution Brain SPECT Imaging
Journal of Neuropsychiatry and Clinical Neurosciences, 12/17/09

See Latest Articles